Floatz logo

DEXAMETHASONE

Myeloproliferative Neoplasm

The First Affiliated Hospital of Soochow UniversitySmall moleculePhase 2Active
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
81/ 100

Competitive context

46 Active assets in the Myeloproliferative Neoplasm cohort.

Asset / SponsorPhaseRating
Fludarabine
Sawa Ito, MD
Phase 4BB
Decitabine
Jacqueline Garcia, MD
Phase 2BB
Cytosin-Arabinosid
Fred Hutchinson Cancer Center
Phase 3BB
Azacitidine
Prelude Therapeutics
Phase 2BB
Cladribine
M.D. Anderson Cancer Center
Phase 2BB

View all 50 →

Same molecule, other indications

DEXAMETHASONE is also rated in:

chemotherapy-induced toxicityDormant
A
Indicative ·
82 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →